| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/26/2002 | US6362194 Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists |
| 03/26/2002 | US6362011 For detection and quantitation of analytes of interest in biochemical and biological substances; for conducting binding assays by measuring luminescence emitted by one or more labeled components of the assay system |
| 03/26/2002 | US6362010 Methods and compositions for release of CD3430 cells from affinity matrices |
| 03/26/2002 | US6362008 Combining sample containing small analyte with known amount of a multiple-analyte conjugated substance, exposing sample to a solid phase sorbent material that has immobilized thereon a first ligand; detecting presence of tagged ligand |
| 03/26/2002 | US6362007 For diagnosis and therapy of systemic lupus erythematosus and related diseases, and diseases in which epstein-barr virus has been implicated |
| 03/26/2002 | US6362003 Hematological reference control composition containing leukocyte analogs, methods of making, and uses thereof |
| 03/26/2002 | US6362002 Characterization of individual polymer molecules based on monomer-interface interactions |
| 03/26/2002 | US6361995 Protection of pancreatic β-cells during islet isolation and assessment of islet viability and candidate diabetes drugs after islet isolation |
| 03/26/2002 | US6361970 A polypeptide encoding an isoleucyl trna synthetase; therapy and screening antibiotic compounds |
| 03/26/2002 | US6361963 A device includes a tray with a coupon receiving chamber for permitting fluid flow through intake and outlet passageways; for preventing bacteria and deposits on stainless steel equipment during pulp and papermaking systems |
| 03/26/2002 | US6361962 A toxin contamination dectection device and method which includes bar coded substrate that is black in color; in the presence of a toxin the bar code changes color which is detected by a scanner; food contamination detection |
| 03/26/2002 | US6361958 A microfluid devic with a microchannel with inport and export opening for fluid flow; a fluid propelling component to control rate of test sample flow, a detector for detecting binding pair in fluid sample and a recirculating arm |
| 03/26/2002 | US6361957 Assay for D-serine transport antagonist and use for treating psychosis |
| 03/26/2002 | US6361956 Biospecific, two photon excitation, fluorescence detection and device |
| 03/26/2002 | US6361955 Immunological process for PSA determination |
| 03/26/2002 | US6361950 A solid phase particle for fluorescence screening of nucleic acids comprising of a transponder with a memory element, a radio-frequency transmitter and photoelectric cells, a nucleic acid probe attached to the outer surface |
| 03/26/2002 | US6361947 Anaylyzing nucleic acid fragments after enzymatic digestion, by hybridization to oligonucleotide probes bound to a solid support; fragments bind to mismatch binding proteins and a hybridization pattern is formed |
| 03/26/2002 | US6361938 Peptides which enhance transport across tissues and methods of identifying and using the same |
| 03/26/2002 | US6361936 Binding microorganisms, cells |
| 03/26/2002 | US6361744 Self-resealing closure for containers |
| 03/26/2002 | US6361700 High molecular weight curable polyesters derived from a short-chain dibasic acid, a polymeric fatty acid, a branched-chain aliphatic diol, and an ethenically unsaturated compound which can react with ends of the polyester chain |
| 03/26/2002 | US6361671 Microfabricated capillary electrophoresis chip and method for simultaneously detecting multiple redox labels |
| 03/26/2002 | US6361206 Microsensor housing |
| 03/26/2002 | US6360619 Aviation fuel sampling safety valve assemblies |
| 03/26/2002 | US6360613 Container and testing device for sport balls |
| 03/26/2002 | US6360588 Materials and methods for the analysis of substances passing through a membrane |
| 03/26/2002 | US6360584 Devices for measuring gases with odors |
| 03/26/2002 | US6360583 Oxygen sensor monitoring |
| 03/26/2002 | US6360582 Method for calibration of chemical sensor in measuring changes in chemical concentration |
| 03/26/2002 | CA2358011A1 Integrated biomolecule sensor, method and apparatus for fabricating the sensor, and method and apparatus for detecting biomolecules using the sensor |
| 03/26/2002 | CA2249036C Body fat determining device |
| 03/26/2002 | CA2232727C Novel variants of green fluorescent protein, gfp |
| 03/26/2002 | CA2180570C Isolated p27 protein and its encoding nucleic acid molecules |
| 03/26/2002 | CA2137551C A novel endothelial cell molecule mediating lymphocyte binding in man |
| 03/26/2002 | CA2123644C Method and apparatus for indirect agglutination immunoassay |
| 03/26/2002 | CA2044265C Apparatus and methods for antimicrobial susceptibility testing of microorganisms |
| 03/26/2002 | CA2029292C Determination of gas properties at reference conditions |
| 03/26/2002 | CA1341351C Production of chimeric mouse-human antibodies with specificity to human tumor antigens |
| 03/25/2002 | CA2320631A1 Monitoring of reinforced concrete vessels and structures |
| 03/25/2002 | CA2320549A1 Biomarkers of transitional cell carcinoma of the bladder |
| 03/22/2002 | CA2357526A1 Mannosidase structures |
| 03/21/2002 | WO2002023467A1 Electrophoretic analysis system having in-situ calibration |
| 03/21/2002 | WO2002023202A2 Method to identify antibody targets based on mass spectrometry (maldi-tof) |
| 03/21/2002 | WO2002023201A2 Use of human phermone polypeptides |
| 03/21/2002 | WO2002023200A2 Human breast cancer biomarkers |
| 03/21/2002 | WO2002023199A2 Method, system, apparatus and device for discovering and preparing chemical compounds |
| 03/21/2002 | WO2002023198A2 Indirect method for the quantitative analysis of the binding capacity present in an aqueous protein solution |
| 03/21/2002 | WO2002023197A2 Methods and compositions for glycosidase assays |
| 03/21/2002 | WO2002023196A2 Fluorescence polarization-based homogeneous assay for deoxynivalenol determination in grains |
| 03/21/2002 | WO2002023195A2 Method for detecting clostridium botulinum neurotoxin serotypes a, b, e and f in a sample |
| 03/21/2002 | WO2002023194A2 Fluorescence polarization-based homogeneous assay for fumonisin determination in grains |
| 03/21/2002 | WO2002023193A1 Glypicans, associated saccharides and binding partners for endostatin |
| 03/21/2002 | WO2002023192A2 Nuclear envelope assembly assay |
| 03/21/2002 | WO2002023191A1 Diagnostic assay |
| 03/21/2002 | WO2002023190A2 Methods and products related to low molecular weight heparin |
| 03/21/2002 | WO2002023189A1 Structural prediction of allosterism |
| 03/21/2002 | WO2002023188A2 Apparatus and method for detecting and classifying chemicals, particles, vira, and bacteria in fluids and air |
| 03/21/2002 | WO2002023186A2 System and method for optimizing drug therapy for the treatment of diseases |
| 03/21/2002 | WO2002023184A1 Method for treatment of insulin resistance in obesity and diabetes |
| 03/21/2002 | WO2002023182A1 Method for the pyrolysis of mercuric chloride for the subsequent analysis of the mercury |
| 03/21/2002 | WO2002023178A1 Method and system for detecting and recording submicron sized particles |
| 03/21/2002 | WO2002023177A1 Method and apparatus for counting submicron sized particles |
| 03/21/2002 | WO2002023176A1 Improvements in and relating to sensors |
| 03/21/2002 | WO2002023165A2 Apparatus for non-destructively testing material |
| 03/21/2002 | WO2002023163A1 Microfabricated crossflow devices and methods |
| 03/21/2002 | WO2002023156A1 Enhancement of in situ hybridization |
| 03/21/2002 | WO2002023154A2 Aggregation-based assays |
| 03/21/2002 | WO2002023153A2 Apparatus for the detection and measurement of particulates in molten metal |
| 03/21/2002 | WO2002023134A1 Spatiotemporal and geometric optimization of sensor arrays for detecting analytes in fluids |
| 03/21/2002 | WO2002022890A2 Compositions, methods and kits for determining the presence of cryptosporidium organisms in a test sample |
| 03/21/2002 | WO2002022886A2 Expression of genes in diabetes mellitus and insulin resistance |
| 03/21/2002 | WO2002022883A1 Combinatorial fluorescence energy transfer tags and uses thereof |
| 03/21/2002 | WO2002022882A2 Target activated nucleic acid biosensor and methods of using same |
| 03/21/2002 | WO2002022874A2 Oligonucleotides for labeling oligonucleotide probes and proteins |
| 03/21/2002 | WO2002022871A2 Polymorphic bone morphogenetic protein 2 |
| 03/21/2002 | WO2002022869A2 Directed evolution method |
| 03/21/2002 | WO2002022867A2 Diagnostic and therapeutic use of a phosphoprotein enriched in astrocytes for alzheimer's disease and related neurodegenerative disorders |
| 03/21/2002 | WO2002022864A1 The method of detecting mutant dspp gene of hereditary opalescent |
| 03/21/2002 | WO2002022862A2 Methods for identifying modulators of protein interactions |
| 03/21/2002 | WO2002022860A2 A system and method for identifying t cell and other epitopes and the like |
| 03/21/2002 | WO2002022859A2 Assessment of ecosystem health by evaluating multiple biomarkers in a nonhuman organism |
| 03/21/2002 | WO2002022858A1 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma |
| 03/21/2002 | WO2002022856A2 Uses of the mammalian ccl18 and related reagents |
| 03/21/2002 | WO2002022855A2 Test-strips with positively charged membranes for tetrazolium based assays |
| 03/21/2002 | WO2002022854A2 Method for the detection and measurement of biomass |
| 03/21/2002 | WO2002022852A2 Method for measuring antithrombin activity |
| 03/21/2002 | WO2002022851A2 Novel tumor-associated marker |
| 03/21/2002 | WO2002022830A2 Transglutaminase gene products |
| 03/21/2002 | WO2002022818A1 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 03/21/2002 | WO2002022813A1 Method of screening hypoglycemic substance by using stat inhibitory factor-1 |
| 03/21/2002 | WO2002022812A1 Methods of assaying or screening compound via detection of nuclear transport receptor inhibition by hepatitis c virus core protein |
| 03/21/2002 | WO2002022809A2 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST |
| 03/21/2002 | WO2002022807A2 Dermatophagoides nucleic acid molecules, proteins and uses thereof |
| 03/21/2002 | WO2002022806A2 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses tehreof |
| 03/21/2002 | WO2002022803A2 Peptide epitopes recognized by antigen specific cd4+ t lymphocytes |
| 03/21/2002 | WO2002022794A2 ENDOTHELIN CONVERTING ENZYMES AND THE AMYLOID βPEPTIDE |
| 03/21/2002 | WO2002022787A2 Differential treatment of selected parts of a single cell with different fluid components |
| 03/21/2002 | WO2002022786A1 Method and cell composition for screening compounds for anti-inflammatory activity |
| 03/21/2002 | WO2002022698A1 Enzyme-mimicking polymers |
| 03/21/2002 | WO2002022685A2 Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |